Coya Therapeutics (COYA) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to -$56.3 million.
- Coya Therapeutics' Retained Earnings fell 4885.75% to -$56.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.3 million, marking a year-over-year decrease of 4885.75%. This contributed to the annual value of -$40.7 million for FY2024, which is 5755.17% down from last year.
- According to the latest figures from Q3 2025, Coya Therapeutics' Retained Earnings is -$56.3 million, which was down 4885.75% from -$54.1 million recorded in Q2 2025.
- Over the past 5 years, Coya Therapeutics' Retained Earnings peaked at -$17.9 million during Q4 2022, and registered a low of -$56.3 million during Q3 2025.
- Its 4-year average for Retained Earnings is -$34.7 million, with a median of -$32.4 million in 2024.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 3944.73% in 2024, then crashed by 6017.43% in 2025.
- Over the past 4 years, Coya Therapeutics' Retained Earnings (Quarter) stood at -$17.9 million in 2022, then tumbled by 44.7% to -$25.9 million in 2023, then tumbled by 57.55% to -$40.7 million in 2024, then tumbled by 38.2% to -$56.3 million in 2025.
- Its Retained Earnings stands at -$56.3 million for Q3 2025, versus -$54.1 million for Q2 2025 and -$48.0 million for Q1 2025.